What were the five biggest stories of the week? Here’s what visitors to this site were reading. 5) AUKUS technology sharing comes a step closer Australian access to foreign technologies on a range of cutting edge industrial technologies is a step closer following progress in the US Senate to the provision of exemptions from export…
Australia’s largest manufacturer, biotechnology and vaccine producer CSL’s brand value has jumped more than 30 percent over the past year to make it the fastest growing brand in its industry, according to a new report from consultant Brand Finance. The report lists CSL’s brand value at US$1.3 billion, which is up 80 percent since 2020.…
University scientists have succeeded in producing a prototype 3D bio-engineered cornea (pictured) as a potential surgical replacement for patients suffering diminished vision and even blindness. A research team led by the University of Sydney’s Professor Gerard Sutton, with researchers from the University of Wollongong (UOW) has produced a prototype with the structural strength that has…
Biotechnology company Vaxxas in partnership with the Queensland Government, has announced the opening of its global headquarters and state-of-the-art manufacturing facility in Brisbane. The company, which is commercialising a needle-free vaccine patch platform, has opened its custom-built 5,500m² Vaxxas Biomedical Facility to support the scale-up of Vaxxas’ needle-free vaccine technology platform. The company’s high-density microarray…
A new Australian Research Council (ARC) Hub to help forge an internationally competitive Australian biopharmaceutical sector using digitisation and artificial intelligence (AI) in pharmaceutical manufacturing has been launched at the University of Melbourne. ARC Acting CEO Dr Richard Johnson inaugrated the ARC Digital Bioprocess Development Hub – a five-year, $18 million research programme, which has…